$3.65
-0.02-0.54%
Last update: Oct 16, 4:00 PM
$3.65
-0.02-0.54%
Fulcrum Therapeutics Inc
FULCNASDAQ
Fulcrum Therapeutics (FULC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.30 | $-0.31 | $-0.29 |
| Actual | $-0.34 | $-0.25 | $-0.31 | $-0.31 |
| Surprise | -54.5% | +16.7% | 0.00% | -6.90% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.07 | $-0.24 | $-0.25 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-0.34 | $-0.22 | -54.5 % |
| Q1 | Apr 27, 2026 | $-0.25 | $-0.30 | 16.7 % |
| Q4 | Feb 24, 2026 | $-0.31 | $-0.31 | 0.00 % |
| Q3 | Oct 29, 2025 | $-0.31 | $-0.29 | -6.90 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 31, 2024 | $80.00M | $36.54M | 118.9 % |
| Q1 | May 13, 2024 | $0 | $360.00K | -100.0 % |
| Q4 | Feb 27, 2024 | $871.00K | $460.00K | 89.3 % |
| Q3 | Nov 7, 2023 | $759.00K | $1.05M | -27.7 % |
